Age is an important factor when treating chronic HCV infection. The prevalence of anti-HCV seropositivity tends to be higher in the elderly than in younger individuals. Aging influence the progression of liver fibrosis and the development of HCC in older people. As life expectancy continues to rise, elderly adults represent a rapidly growing proportion of the population.
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
Please login to comment on this article